Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Remifentanil and Nicardipine Infusions for Controlled Hypotension in Elective Nasal Surgery Where Bleeding Control is Critical: A Randomized Controlled Trial

NCT07660562 is registered in ClinicalTrials.gov with Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital as lead sponsor.

NCT NCT07660562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07660562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Remifentanil and Nicardipine Infusions for Controlled Hypotension in Elective Nasal Surgery Where Bleeding Control is Critical: A Randomized Controlled Trial
Lead sponsor
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 25, 2026
Completion date
July 15, 2026
Enrollment
44 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, controlled hypotension for nasal surgeries, nasal surgery